Objective monitoring of neuromuscular block should become the standard of care.
El-Orbany
M
M
D000732:Androstanols; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D004347:Drug Interactions; D006801:Humans; D008991:Monitoring, Physiologic / Q000592:standards*; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents; D011239:Prednisolone / Q000009:adverse effects; D000077123:Rocuronium
D000732:Androstanols; D000893:Anti-Inflammatory Agents; D003473:Neuromuscular Nondepolarizing Agents; D011239:Prednisolone; D000077123:Rocuronium